orphenadrine has been researched along with Cognition Disorders in 1 studies
Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gisselmann, A | 1 |
| Marin, A | 1 |
| Simon, P | 1 |
1 other study available for orphenadrine and Cognition Disorders
| Article | Year |
|---|---|
[Pilot study on the effects of an antiparkinson anticholinergic agent during depressive conditions].
Topics: Adult; Aged; Cognition Disorders; Depression; Female; Humans; Male; Middle Aged; Orphenadrine; Sleep | 1975 |